Torrent Pharmaceuticals Limited has informed the Exchange about Transcript
TORNTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Torrent Pharmaceuticals has shared the transcript of its conference call with analysts and investors held after announcing financial results for the quarter and nine months ended 31st December 2025. The transcript is available on the company's website. This is a routine regulatory filing under SEBI's listing rules, following up on the earlier intimation dated 2nd February 2026. No new financial figures or guidance are disclosed in this particular filing.
No direct impact on the stock. Investors who want detailed commentary from management on Q3 performance can now read the full transcript, which may help clarify strategy and outlook.